PLC

DRUG2 trials

Sponsors

Sigma-Tau Research, Inc., King's College London

Conditions

Autism Spectrum DisorderIntermittent ClaudicationPeripheral Vascular Diseases

Phase 3

Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)

CompletedNCT00399919

Sigma-Tau Research, Inc.Intermittent Claudication, Peripheral Vascular Diseases

Start: 2006-04-30End: 2008-03-31Updated: 2011-08-25

Unknown Phase

Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder

CompletedNCT03537950

King's College LondonAutism Spectrum Disorder

Start: 2016-08-22End: 2017-03-01Updated: 2024-03-05

Related Papers

Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin.

2021-07-0120 citations